NM_002181.4:c.1128T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002181.4(IHH):​c.1128T>C​(p.Thr376Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.815 in 1,612,922 control chromosomes in the GnomAD database, including 537,795 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.86 ( 56256 hom., cov: 35)
Exomes 𝑓: 0.81 ( 481539 hom. )

Consequence

IHH
NM_002181.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.798

Publications

22 publications found
Variant links:
Genes affected
IHH (HGNC:5956): (Indian hedgehog signaling molecule) This gene encodes a member of the hedgehog family of proteins. The encoded preproprotein is proteolytically processed to generate multiple protein products, including an N-terminal fragment that is involved in signaling. Hedgehog family proteins are essential secreted signaling molecules that regulate a variety of developmental processes including growth, patterning and morphogenesis. The protein encoded by this gene specifically plays a role in bone growth and differentiation. Mutations in this gene are the cause of brachydactyly type A1, which is characterized by shortening or malformation of the fingers and toes. Mutations in this gene are also the cause of acrocapitofemoral dysplasia. [provided by RefSeq, Nov 2015]
IHH Gene-Disease associations (from GenCC):
  • brachydactyly type A1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • acrocapitofemoral dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-219055315-A-G is Benign according to our data. Variant chr2-219055315-A-G is described in ClinVar as Benign. ClinVar VariationId is 593247.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.798 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.953 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IHHNM_002181.4 linkc.1128T>C p.Thr376Thr synonymous_variant Exon 3 of 3 ENST00000295731.7 NP_002172.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IHHENST00000295731.7 linkc.1128T>C p.Thr376Thr synonymous_variant Exon 3 of 3 1 NM_002181.4 ENSP00000295731.5

Frequencies

GnomAD3 genomes
AF:
0.856
AC:
130272
AN:
152186
Hom.:
56199
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.961
Gnomad AMI
AF:
0.707
Gnomad AMR
AF:
0.836
Gnomad ASJ
AF:
0.749
Gnomad EAS
AF:
0.907
Gnomad SAS
AF:
0.822
Gnomad FIN
AF:
0.875
Gnomad MID
AF:
0.718
Gnomad NFE
AF:
0.801
Gnomad OTH
AF:
0.828
GnomAD2 exomes
AF:
0.835
AC:
207168
AN:
248116
AF XY:
0.829
show subpopulations
Gnomad AFR exome
AF:
0.965
Gnomad AMR exome
AF:
0.867
Gnomad ASJ exome
AF:
0.749
Gnomad EAS exome
AF:
0.919
Gnomad FIN exome
AF:
0.878
Gnomad NFE exome
AF:
0.800
Gnomad OTH exome
AF:
0.796
GnomAD4 exome
AF:
0.811
AC:
1184656
AN:
1460618
Hom.:
481539
Cov.:
69
AF XY:
0.810
AC XY:
588270
AN XY:
726596
show subpopulations
African (AFR)
AF:
0.962
AC:
32190
AN:
33476
American (AMR)
AF:
0.859
AC:
38398
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.749
AC:
19565
AN:
26128
East Asian (EAS)
AF:
0.877
AC:
34792
AN:
39692
South Asian (SAS)
AF:
0.813
AC:
70127
AN:
86238
European-Finnish (FIN)
AF:
0.876
AC:
45929
AN:
52418
Middle Eastern (MID)
AF:
0.724
AC:
4175
AN:
5766
European-Non Finnish (NFE)
AF:
0.801
AC:
890392
AN:
1111820
Other (OTH)
AF:
0.813
AC:
49088
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
14437
28874
43310
57747
72184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20826
41652
62478
83304
104130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.856
AC:
130387
AN:
152304
Hom.:
56256
Cov.:
35
AF XY:
0.859
AC XY:
64010
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.961
AC:
39951
AN:
41586
American (AMR)
AF:
0.835
AC:
12791
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.749
AC:
2599
AN:
3470
East Asian (EAS)
AF:
0.908
AC:
4685
AN:
5162
South Asian (SAS)
AF:
0.822
AC:
3968
AN:
4826
European-Finnish (FIN)
AF:
0.875
AC:
9303
AN:
10628
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.801
AC:
54491
AN:
68004
Other (OTH)
AF:
0.828
AC:
1750
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
993
1987
2980
3974
4967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.810
Hom.:
72680
Bravo
AF:
0.858
Asia WGS
AF:
0.840
AC:
2920
AN:
3478
EpiCase
AF:
0.786
EpiControl
AF:
0.790

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 31, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Acrocapitofemoral dysplasia Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.8
DANN
Benign
0.58
PhyloP100
0.80
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs394452; hg19: chr2-219920037; COSMIC: COSV55392655; COSMIC: COSV55392655; API